The Federal Trade Commission is launching a probe into recent shortages of chemotherapies and other drugs, examining the role played by companies that help buy and distribute the bulk of medicines sold to U.S. hospitals.
The inquiry shines a spotlight on a little-noticed corner of the drug supply chain—but one that can have an outsize impact on stores of critical medicines.
Top 7 Rugged Luxury Phones: Durability Meets Sophistication in 2026
In 2026, the mobile industry has witnessed a paradigm shift where elite craftsmanship no longer sacrifices structural integrity. The Top
